Drugs firm Aspen is to pay the NHS £8 million following an investigation into the supply of a life-saving drug to thousands of patients across the country.
It is the first time the Competition and Markets Authority (CMA) will secure such a payment to the NHS in one of its pharmaceutical investigations. It follows an investigation conducted by the CMA into suspected anti-competitive arrangements regarding the supply of fludrocortisone acetate 0.1 mg tablets.
Thousands of NHS patients depend on fludrocortisone, which is only available on prescription, usually to treat primary or secondary adrenal insufficiency, more commonly known as Addison’s Disease. The drug is paid for by the NHS and, ultimately, the UK taxpayers.
Scheduled Maintenance We are making some improvements to your service, which will require essential planned maintenance and downtime during the weekend of Saturday 25th and Sunday 26th January 2020. Your service will be offline during the period below: Planned Start: Saturday 25th January, 09:00 BST | Planned End: Sunday 26th January, 18:00 BST The downtime will enable a significant upgrade to your service, paving the way for higher performance levels and new features and functionality.
We will be working to ensure that the downtime experienced will be minimal and apologise for any inconvenience which this may cause.